Imagin Medical

Imagin Medical is building a first-class urological oncology company, developing technologies to better visualize and treat urological cancers, including bladder and prostate cancer, through minimally invasive surgery. We believe the company’s first product, the i/Blue Imaging System™, along with its advanced proprietary optics and light sensors, will significantly enhance the efficiency and accuracy of bladder cancer detection, contributing to improved surgical management of this disease. Imagin’s follow-up product, the enCAGE Coil™ Precision Ablation System for prostate cancer, is a bipolar radiofrequency-based focal therapy probe that allows surgeons to predefine margins. This feature addresses limitations of other forms of prostate cancer treatment, which lack the ability to precisely target only cancer cells, potentially damaging the remaining prostate and surrounding erectile nerves, leading to impaired urinary and sexual function. Imagin’s proprietary technology holds promise to expand patient accessibility, improve treatment outcomes, and enhance quality of life.